Panpan Jiang

The Key Laboratory Of Biomedical Information Engineering Of Ministry Of Education
Xi'an, 710049, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Piezo1 Activation Improves NSCLC Liver Metastasis Immunotherapy by Overriding Matrix Stiffness-Mediated Bimodal PD-L1/CXCL10 Regulation.

Piezo1 Activation Improves NSCLC Liver Metastasis Immunotherapy by Overriding Matrix Stiffness-Mediated Bimodal PD-L1/CXCL10 Regulation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 21, 2025

Construction of a nomogram model based on biomarkers for liver metastasis in non-small cell lung cancer.

Construction of a nomogram model based on biomarkers for liver metastasis in non-small cell lung cancer.

Journal: Thoracic cancer

Published: May 30, 2024

Stimuli-Responsive Aptamer-Drug Conjugates for Targeted Drug Delivery and Controlled Drug Release.

Stimuli-Responsive Aptamer-Drug Conjugates for Targeted Drug Delivery and Controlled Drug Release.

Journal: Advanced healthcare materials

Published: March 18, 2024

DNAM-1 regulates the proliferation and function of T regulatory type 1 cells via the IL-2/STAT5 pathway

DNAM-1 regulates the proliferation and function of T regulatory type 1 cells via the IL-2/STAT5 pathway

Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University

Published: October 10, 2022

Characteristics of the immunogenicity and tumor immune microenvironment in HER2-amplified lung adenocarcinoma.

Characteristics of the immunogenicity and tumor immune microenvironment in HER2-amplified lung adenocarcinoma.

Journal: Frontiers in immunology

Published: September 12, 2022

First-line chemotherapy plus immune checkpoint inhibitors or bevacizumab in advanced non-squamous non-small-cell lung cancer without EGFR mutations or ALK fusions.

First-line chemotherapy plus immune checkpoint inhibitors or bevacizumab in advanced non-squamous non-small-cell lung cancer without EGFR mutations or ALK fusions.

Journal: Immunotherapy

Published: March 09, 2022

Effect of Concomitant Use of Analgesics on Prognosis in Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.

Effect of Concomitant Use of Analgesics on Prognosis in Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.

Journal: Frontiers in immunology

Published: January 25, 2022

First-line immune-based combination therapies for advanced non-small cell lung cancer: A Bayesian network meta-analysis.

First-line immune-based combination therapies for advanced non-small cell lung cancer: A Bayesian network meta-analysis.

Journal: Cancer medicine

Published: July 25, 2021

An Indirect Comparison Between Nivolumab + Ipilimumab + Two Cycles of Chemotherapy vs. Pembrolizumab + Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer.

An Indirect Comparison Between Nivolumab + Ipilimumab + Two Cycles of Chemotherapy vs. Pembrolizumab + Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer.

Journal: Frontiers in oncology

Published: April 20, 2021

Effect of Immune-Related Adverse Events and Pneumonitis on Prognosis in Advanced Non-Small Cell Lung Cancer: A Comprehensive Systematic Review and Meta-analysis.

Effect of Immune-Related Adverse Events and Pneumonitis on Prognosis in Advanced Non-Small Cell Lung Cancer: A Comprehensive Systematic Review and Meta-analysis.

Journal: Clinical lung cancer

Published: March 09, 2021

Porcine JAB1 significantly enhances apoptosis induced by staurosporine.

Porcine JAB1 significantly enhances apoptosis induced by staurosporine.

Journal: Cell death & disease

Published: May 29, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026